The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers.
about
The in vivo effect of VIP, PACAP-38 and PACAP-27 and mRNA expression of their receptors in rat middle meningeal arteryNeuropeptide PACAP in mouse liver ischemia and reperfusion injury: immunomodulation by the cAMP-PKA pathwaySources of variability of resting cerebral blood flow in healthy subjects: a study using ¹³³Xe SPECT measurementsPituitary adenylate cyclase-activating polypeptide (PACAP) has a neuroprotective function in dopamine-based neurodegeneration in rat and snail parkinsonian models.The PACAP receptor: a novel target for migraine treatment.Pearls and pitfalls in human pharmacological models of migraine: 30 years' experience.Pleiotropic and retinoprotective functions of PACAP.Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38.PACAP38: Emerging Drug Target in Migraine and Cluster Headache.Toll-like receptor 4 signaling is involved in PACAP-induced neuroprotection in BV2 microglial cells under OGD/reoxygenation.Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients.The cholinomimetic agent carbachol induces headache in healthy subjects.PACAP38 induces migraine-like attacks in patients with migraine without aura.Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system.Cranial parasympathetic activation induces autonomic symptoms but no cluster headache attacks.Targeted Pituitary Adenylate Cyclase-Activating Peptide Therapies for Migraine.PACAP and its receptors in cranial arteries and mast cells.PACAP38 in human models of primary headaches.Pituitary adenylate cyclase-activating polypeptide is a potent broad-spectrum antimicrobial peptide: Structure-activity relationships.Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteersPharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary arteryPACAP38 and PAC receptor blockade: a new target for headache?
P2860
Q28570985-56CF2A0D-D28D-433D-A772-0EA3D9313DFEQ36342098-20993E27-E8C3-4733-A9BD-CB73D703C93BQ36839954-28699FFE-D38A-407C-A879-79FE7DEB7BD0Q37644437-CBA8BB1F-470A-4CF1-9009-AB53EE501E70Q37739591-ED23BDE4-8DAC-4AD1-804C-153B54BDDE7BQ38106681-D404092C-35D7-4E6D-A902-0E0739A08B0AQ38871154-7FE0D540-477D-49C1-860B-1DC321993AACQ39255351-034D2CF2-0A5A-49EE-BB01-24F3120335F6Q39293515-75B5A6BE-1845-45BD-950D-709B53E623C8Q39340625-13249E8F-447A-4CEB-9AC6-9E40AF11B1ECQ40844188-DCD342D9-320B-4ED1-A30C-03C272D98560Q46163297-7548984B-F4F7-4BA9-8EA9-87F6CFDF1384Q46217464-2262147C-0EDA-49C5-A287-FC92DB4BFD51Q46399968-D32A25CB-E70D-48EE-A480-BE7CF6C357E8Q47693056-BB5B05A1-FD13-44B5-A272-6936DE782C50Q49721275-AB4A2931-EEC6-4553-85CC-ED2FFF3F10DAQ49825872-18AD7322-6E15-4F05-BB36-8A8324F01215Q49907816-B9BE583E-4882-4A5F-91B4-1D358B6E3E84Q52588734-875F4018-4281-48FE-9DAB-3EEA6C6533BAQ57024014-11B4E825-63B9-4369-B3CD-44690968F0FFQ57024130-109F14DA-CC72-4FC3-A7CD-71C7FCB003F1Q58797905-C02EE065-202B-484A-8251-DC36C0A7827C
P2860
The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers.
@en
type
label
The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers.
@en
prefLabel
The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers.
@en
P2093
P50
P1433
P1476
The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers
@en
P2093
Jan Fahrenkrug
John Thomas Sitarz
Steffen Birk
P304
P356
10.1016/J.REGPEP.2006.12.010
P577
2007-01-03T00:00:00Z